ROCHESTER, N.Y., Dec. 11 /PRNewswire/ -- Lucid, Inc. (http://www.lucid-tech.com), a leading U.S. cellular imaging and technology company, has appointed Dr. Colin Stahel as Director, Asia Pacific Region.
Based in Sydney, Australia, Stahel was selected for the newly created position based on his extensive medical technology experience.
"With over twenty years of experience in the development of medical technology and pre-cancer and cancer detection equipment, Stahel is a welcome addition to the Lucid team," said Jay Eastman, chairman and CEO of Lucid, Inc (http://www.lucid-tech.com). "His knowledge of the field will suit his new responsibilities in the international community."
Previously, Stahel was the senior manager with Polartechnics where he worked directly with the SolarScan digital dermatoscope and TruScreen Division for real time detection of cervical cancer, both based in Australia.
Dr. Colin D. Stahel holds a Ph.D. in physiology from the Faculty of Medicine, University of Tasmania in Australia, and a MBA from Macquarie University of Australia.
Lucid is the creator of the non-invasive VivaScope confocal microscope that provided cellular resolution images of skin, and of the VivaNet, an internet-based, DICOM-compliant medical information systems that enables the transfer of VivaScope digital images between practitioners and pathologists for rapid review of confocal images. Lucid's VivaScopes are in regular use throughout the United States, Europe, and Australia.
For more information about Lucid Inc., visit http://www.Lucid-tech.com or call 1-585-239-9800.
About Lucid, Inc.
Lucid Inc., based in Rochester, New York, is a medical device and
information company dedicated to creating innovative cellular imaging
technology and using the Internet
|SOURCE Lucid, Inc.|
Copyright©2007 PR Newswire.
All rights reserved